The UK is doing more than most countries to support access to Covid vaccines for the poorest populations in the world, but it is not transparent enough about the deals it is doing at home, according to an international aid organisation launching a tracker.

The One campaign has given countries and pharmaceutical companies scores for the efforts they have made to ensure the poorest get vaccines. In the vaccine access test no country or company scores green, the top rating, classed as aiding global access to vaccines.

The European commission, France, Germany, Italy, the UK, Saudi Arabia and one company – AstraZeneca, which is making a leading vaccine with Oxford University – score yellow, meaning room for improvement. In the red zone, said to be “impeding access” to vaccines, are 15 countries including the US, China and Russia.

Seven pharmaceutical companies making vaccines are also in the red zone. Moderna in the US, which is one, has stated that its vaccine is a commercial proposition, for sale to those who can pay a high price.

Romilly Greenhill, the UK director of the One campaign, said wealthy countries should ensure low-income nations got access to Covid vaccines for both moral and pragmatic reasons. “It is in the UK’s self-interest,” she said. “The virus could go to Africa, mutate and come back in another form, where the vaccine no longer works.”

The British government has pledged more than $1.2bn to the ACT-Accelerator, a global initiative to ensure vaccines are shared globally, and it has encouraged other countries to join the effort, including by hosting events.

It “clearly gets that this pandemic requires a global solution,” Greenhill said, “providing significant funding and encouraging other donors to step up. This leadership is vital, but they need to go further to ensure poor countries don’t lose out.”

But it has placed orders for six different vaccines, totalling 340m doses. It should be transparent about the price it was paying, Greenhill said, and ensure any contract it signed aligned with World Health Organization guidance on phasing the delivery of vaccines around the world.

“This is a moment that demands international unity and collective action, but we’ve got too many laggards and not enough leaders,” said Gayle Smith, CEO and president of the One campaign, which was co-founded by U2’s Bono. “And every time that our political leaders fail to act not just nationally but also internationally, the lifespan of the pandemic increases.”

Contributor

Sarah Boseley Health editor

The GuardianTramp

Related Content

Article image
The Guardian view on coronavirus and vaccine scepticism: time to act | Editorial
Editorial: Plans for mass immunisation against Covid-19 are developing fast, but concerns must be addressed

Editorial

22, Nov, 2020 @6:30 PM

Article image
UK orders extra Covid vaccines for autumn 2022 booster campaign
Pfizer reportedly asked to supply 35m more doses, with final go-ahead for this year’s programme still awaited

Andrew Sparrow Political correspondent

11, Aug, 2021 @9:51 AM

Article image
Germany challenges AstraZeneca Covid vaccine efficacy reports
Report said ministers expected EU regulator’s assessment to show jab was only 8% effective among over-65s

Philip Oltermann in Berlin

26, Jan, 2021 @11:07 AM

Article image
‘We haven’t finished the job’: JVT reflects on 18 months of Covid
Exclusive: Listen to the experts, says deputy chief medical officer Jonathan Van-Tam, not the celebrities

Nicola Davis Science correspondent

24, Sep, 2021 @10:32 AM

Article image
Ireland suspends AstraZeneca Covid vaccine over blood clot concerns
Suspension follows similar move in Ireland due to reports in Norway of blood clots despite no proof of a link

Sarah Boseley Health editor

14, Mar, 2021 @11:38 PM

Article image
How does the Pfizer/BioNTech vaccine work and who will get it?
Covid vaccine with an efficacy of almost 95% has been authorised by the UK medicines regulator

Nicola Davis Science correspondent

02, Dec, 2020 @7:16 AM

Article image
Oxford Covid vaccine trial suspension: what happens next?
Tests have been paused after a UK volunteer became ill. How will it affect the search for a cure?

Sarah Boseley Health editor

09, Sep, 2020 @11:23 AM

Article image
I’ve had my first vaccine jab. It gives me hope of liberation... but not yet
Exactly a year after his first story about coronavirus, our science editor received the Pfizer injection last week. Here he reflects on a remarkable scientific achievement

Robin McKie Science Editor

24, Jan, 2021 @7:00 AM

Article image
Oxford Covid vaccine has 10% efficacy against South African variant, study suggests
Small-scale trial of vaccine shows it offers very little protection against mild to moderate infection

Kevin Rawlinson and Ian Sample

08, Feb, 2021 @1:54 PM

Article image
Why experts say there is no basis to claims in Germany about efficacy of AstraZeneca vaccine
Analysis: Drug company and scientific partners at Oxford University have strongly pushed back against German press report

Nicola Davis and Philip Oltermann

26, Jan, 2021 @4:59 PM